biotin has been researched along with Experimental Mammary Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Fu, Q; Guo, L; Huang, M; Peng, Y; Pu, Y; Wu, Y; Zheng, Y | 1 |
Fujii, H; Hiraoka, M; Kizaka-Kondoh, S; Kudo, T; Miyano, A; Mutou, Y; Ogawa, K; Ono, M; Saji, H; Ueda, M; Umeda, IO | 1 |
Atyabi, F; Borougeni, AT; Dinarvand, R; Khorramizadeh, MR; Mansoori, P; Nouri, FS; Taheri, A | 1 |
Hodgkiss, RJ; Parrick, J; Porssa, M; Stratford, MR | 1 |
Bastert, G; Chen, XL; Kaul, S | 1 |
Junker, JL; Pardue, RL; Shih, TY; Takahashi, K; Ward, JM; Weislow, OS | 1 |
6 other study(ies) available for biotin and Experimental Mammary Neoplasms
Article | Year |
---|---|
Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotin; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Female; Glucose; Humans; Ligands; Liposomes; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Paclitaxel; Structure-Activity Relationship | 2020 |
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.
Topics: Animals; Autoradiography; Biotin; Female; Fluorescent Antibody Technique, Direct; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Proteins; Nitroimidazoles; Radiopharmaceuticals; Recombinant Fusion Proteins; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Biotin; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Nanoconjugates; Nanomedicine; Serum Albumin | 2011 |
Bioreductive markers for hypoxic cells: 2-nitroimidazoles with biotinylated 1-substituents.
Topics: Animals; Avidin; Bacterial Proteins; Biomarkers; Biotin; Cell Hypoxia; Chromatography, High Pressure Liquid; Flow Cytometry; Fluorescein-5-isothiocyanate; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitroimidazoles; Oxidation-Reduction; Oxygen; Streptavidin; Tumor Cells, Cultured | 1994 |
Tumour-associated antigens of mammary carcinomas recognized by human monoclonal antibody 1G12.
Topics: Animals; Anions; Antibodies, Monoclonal; Antigens, Neoplasm; Biotin; Breast Neoplasms; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Female; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Sodium Dodecyl Sulfate | 1991 |
Immunocytochemical localization of RasHa p21 in normal and neoplastic cells in fixed tissue sections from Harvey sarcoma virus-infected mice.
Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Fluorescent Antibody Technique; Harvey murine sarcoma virus; Histocytochemistry; Liver Neoplasms; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Oncogene Protein p21(ras); Rats; Rats, Inbred F344; Sarcoma, Experimental; Sheep; Skin Neoplasms | 1986 |